SH2B1 and fatty liver disease: Although there are substantial experimental data to support the role of SH2B1 in mediating the phenotypes of obesity, T2D, and fatty liver disease, further studies are needed to examine the potential phenotypic contribution of other coding genes and noncoding RNAs affected by the 16p11.2 BP2–3 deletion.